A Phase 1 Dose Escalation Study Of Milademetan In Combination With 5-Azacitidine (Aza) In Patients With Acute Myeloid Leukemia (Aml) Or High-Risk Myelodysplastic Syndrome (Mds)
BLOOD(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
BLOOD(2019)